Translating curcumin to the clinic for lung cancer prevention: Evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies

Journal of Pharmacology and Experimental Therapeutics

Volumn 350, Issue 3, 2014, Pages 483-494

  Howells, Lynne M ^a   Mahale, Jagdish ^a   Sale, Stewart ^a   McVeigh, Laura ^a   Steward, William P ^a   Thomas, Anne ^a   Brown, Karen ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 ARYLIDENE CURCUMIN; 4 [3,5 BIS(2 CHLOROBENZYLIDENE 4 OXO PIPERIDINE 1 YL)] 4 OXO 2 BUTENOIC ACID; 5 HYDROXY 1 (4 HYDROXY 3 METHOXYPHENYL) 7 (5 METHYLFURAN 2 YL)HEPTA 1,4,6 TRIEN 3 ONE (2A); ANTINEOPLASTIC AGENT; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; DOCETAXEL; DOXORUBICIN; ERLOTINIB; GEFITINIB; GEMCITABINE; HYDRAZINOBENZOYLCURCUMIN; NAVELBINE; PHOSPHOSULINDAC; PIPERINE; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; LUNG CANCER; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; SECONDARY PREVENTION; TERTIARY PREVENTION STRATEGY; TUMOR XENOGRAFT;

ACUTE LUNG INJURY; ANIMALS; CELL LINE, TUMOR; CURCUMIN; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; PRIMARY PREVENTION; SECONDARY PREVENTION; SMOKING CESSATION; TERTIARY PREVENTION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84905014956     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.216333     Document Type: Review

References (138)

1. Alexandrow MG, Song LJ, Altiok S, Gray J, Haura EB, and Kumar NB (2012) Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. Eur J Cancer Prev 21:407-412.
2. Anand P, Kunnumakkara AB, Newman RA, and Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807-818.
3. Arnold AM, Browman GP, Levine MN, D'Souza T, Johnstone B, Skingley P, TurnerSmith L, Cayco R, Booker L, and Newhouse M, et al. (1992) The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. Br J Cancer 65:737-743.
4. Avasarala S, Zhang F, Liu G, Wang R, London SD, and London L (2013) Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS ONE 8:e57285.
5. Bansal S and Chhibber S (2010) Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice. J Med Microbiol 59:429-437.
6. Bettio D, Cariboni U, Venci A, Valente M, Spaggiari P, and Alloisio M (2012) Cytogenetic findings in lung cancer that illuminate its biological history from adenomatous hyperplasia to bronchioalveolar carcinoma to adenocarcinoma: a case report. Exp Ther Med 4:1032-1034.
7. Brambilla E and Gazdar A (2009) Pathogenesis of lung cancer signalling pathways: roadmap for therapies. Eur Respir J 33:1485-1497.
8. Chanvorachote P, Pongrakhananon V, Wannachaiyasit S, Luanpitpong S, Rojanasakul Y, and Nimmannit U (2009) Curcumin sensitizes lung cancer cells to cisplatin-induced apoptosis through superoxide anion-mediated Bcl-2 degradation. Cancer Invest 27:624-635.
9. Chen QY, Jiao DM, Yao QH, Yan J, Song J, Chen FY, Lu GH, and Zhou JY (2012) Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines. Int J Oncol 40:1561-1568.
10. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, and Tsai MF, et al (2008) Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68:7428-7438.
11. Chen L, Tian G, Shao C, Cobos E, and Gao W (2010a) Curcumin modulates eukaryotic initiation factors in human lung adenocarcinoma epithelial cells. Mol Biol Rep 37: 3105-3110.
12. Chen QY, Lu GH, Wu YQ, Zheng Y, Xu K, Wu LJ, Jiang ZY, Feng R, and Zhou JY (2010b) Curcumin induces mitochondria pathway mediated cell apoptosis in A549 lung adenocarcinoma cells. Oncol Rep 23:1285-1292.
13. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, Chou HY, Chien CT, Chen WJ, and Lee YT, et al (2004) Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 65:99-110.
14. Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ, and Lv GY (2014) Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. J Nutr Biochem 25:177-185.
15. Cheng KW, Wong CC, Mattheolabakis G, Xie G, Huang L, and Rigas B (2013) Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics. Int J Oncol 43:895-902.
16. Cho YJ, Yi CO, Jeon BT, Jeong YY, Kang GM, Lee JE, Roh GS, and Lee JD (2013) Curcumin attenuates radiation-induced inflammation and fibrosis in rat lungs. Korean J Physiol Pharmacol 17:267-274.
17. Couraud S, Zalcman G, Milleron B, Morin F, and Souquet PJ (2012) Lung cancer in never smokers - a review. Eur J Cancer 48:1299-1311.
18. Cui J, Meng X, Gao X, and Tan G (2010) Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells. Mol Biol Rep 37:1627-1632.
19. Dance-Barnes ST, Kock ND, Moore JE, Lin EY, Mosley LJ, D'Agostino RB, Jr, McCoy TP, Townsend AJ, and Miller MS (2009) Lung tumor promotion by curcumin. Carcinogenesis 30:1016-1023.
20. Dragnev K, You M, Wang Y, and Lubet R (2013) Lung cancer chemoprevention: difficulties, promise and potential agents? Expert Opin Investig Drugs 22:35-47.
21. Field RW and Withers BL (2012) Occupational and environmental causes of lung cancer. Clin Chest Med 33:681-703.
22. Flora G, Gupta D, and Tiwari A (2013) Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst 30:331-368.
23. Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ, and Berry DP (2004) Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90:1011-1015.
24. Gower A, Wang Y, and Giaccone G (2014) Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer. J Mol Med (Berl) 92:697-707.
25. Gray JE, Altiok S, Alexandrow MG, Walsh FW, Chen J, Schell MJ, Tai DF, and Bepler G (2013) Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers. Cancer 119:1023-1032.
26. Hamdy MA, El-Maraghy SA, and Kortam MA (2012) Modulatory effects of curcumin and green tea extract against experimentally induced pulmonary fibrosis: a comparison with N-acetyl cysteine. J Biochem Mol Toxicol 26:461-468.
27. Heger M, van Golen RF, Broekgaarden M, and Michel MC (2014) The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer. Pharmacol Rev 66:222-307.
28. Heimburger DC, Alexander CB, Birch R, Butterworth C.E., Jr, Bailey WC, and Krumdieck CL (1988) Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 259:1525-1530.
29. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, and Ridker PM, et al (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145-1149.
30. Herbst RS, Heymach JV, and Lippman SM (2008) Lung cancer. N Engl J Med 359: 1367-1380.
31. Howells LM, Moiseeva EP, Neal CP, Foreman BE, Andreadi CK, Sun YY, Hudson EA, and Manson MM (2007) Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin 28:1274-1304.
32. Hubaux R, Becker-Santos DD, Enfield KS, Lam S, Lam WL, and Martinez VD (2012) Arsenic, asbestos and radon: emerging players in lung tumorigenesis. Environ Health 11:89.
33. Irving GR, Howells LM, Sale S, Kralj-Hans I, Atkin WS, Clark SK, Britton RG, Jones DJ, Scott EN, and Berry DP, et al (2013) Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration - a clinical pilot study including assessment of patient acceptability. Cancer Prev Res (Phila) 6:119-128.
34. Irving GR, Karmokar A, Berry DP, Brown K, and Steward WP (2011) Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 25:519-534.
35. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, and Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106-130.
36. Jeremy George P, Banerjee AK, Read CA, O'Sullivan C, Falzon M, Pezzella F, Nicholson AG, Shaw P, Laurent G, and Rabbitts PH (2007) Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 62: 43-50.
37. Jiang AP, Zhou DH, Meng XL, Zhang AP, Zhang C, Li XT, and Feng Q (2014) Down-regulation of epidermal growth factor receptor by curcumin-induced UBE1L in human bronchial epithelial cells. J Nutr Biochem 25:241-249.
38. Kaiser J (2014) Biomedical research. Antioxidants could spur tumors by acting on cancer gene. Science 343:477.
39. Kalpana C and Menon VP (2004) Curcumin ameliorates oxidative stress during nicotine-induced lung toxicity in Wistar rats. Ital J Biochem 53:82-86.
40. Kamangar F, Qiao YL, Yu B, Sun XD, Abnet CC, Fan JH, Mark SD, Zhao P, Dawsey SM, and Taylor PR (2006) Lung cancer chemoprevention: a randomized, doubleblind trial in Linxian, China. Cancer Epidemiol Biomarker Prev 15:1562-1564.
41. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, and Clamon G, et al (2013) Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol 31:4179-4187.
42. Kaushik G, Kaushik T, Yadav SK, Sharma SK, Ranawat P, Khanduja KL, and Pathak CM (2012) Curcumin sensitizes lung adenocarcinoma cells to apoptosis via in-tracellular redox status mediated pathway. Indian J Exp Biol 50:853-861.
43. Keith RL (2009) Chemoprevention of lung cancer. Proc Am Thorac Soc 6:187-193.
44. Keith RL, Blatchford PJ, Kittelson J, Minna JD, Kelly K, Massion PP, Franklin WA, Mao J, Wilson DO, and Merrick DT, et al (2011) Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev Res (Phila) 4:793-802.
45. Kelley MJ, Glaser EM, Herndon JE, 2nd, Becker F, Bhagat R, Zhang YJ, Santella RM, Carmella SG, Hecht SS, Gallot L, Schilder L, Crowell JA, Perloff M, Folz RJ, and Bergan RC (2005) Safety and efficacy of weekly oral oltipraz in chronic smokers. Cancer Epidemiol Biomarkers Prev 14:892-899.
46. Kelly K, Kittelson J, Franklin WA, Kennedy TC, Klein CE, Keith RL, Dempsey EC, Lewis M, Jackson MK, and Hirsch FR, et al (2009) A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer. Cancer Prev Res (Phila) 2:440-449.
47. Khan MS, Priyadarshini M, and Bano B (2009) Preventive effect of curcumin and quercetin against nitric oxide mediated modification of goat lung cystatin. J Agric Food Chem 57:6055-6059.
48. Kim ES, Hong WK, Lee JJ, Mao L, Morice RC, Liu DD, Jimenez CA, Eapen GA, Lotan R, and Tang X, et al (2010) Biological activity of celecoxib in the bronchial epithelium of current and former smokers. Cancer Prev Res (Phila) 3:148-159.
49. Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman SM, and Ro JY, et al (2000) N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 6:2973-2979.
50. Lam S, leRiche JC, McWilliams A, Macaulay C, Dyachkova Y, Szabo E, Mayo J, Schellenberg R, Coldman A, and Hawk E, et al. (2004) A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res 10:6502-6511.
51. Lam S, MacAulay C, Le Riche JC, Dyachkova Y, Coldman A, Guillaud M, Hawk E, Christen MO, and Gazdar AF (2002) A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst 94: 1001-1009.
52. Lee J, Im YH, Jung HH, Kim JH, Park JO, Kim K, Kim WS, Ahn JS, Jung CW, and Park YS, et al (2005) Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334:313-318.
53. Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, Solomides CC, Javvadi P, Koumenis C, and Cengel KA, et al (2010) Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat Res 173:590-601.
54. Lee JS, Lippman SM, Benner SE, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, and Fritsche HA, Jr, et al. (1994) Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 12:937-945.
55. Li S, Liu Z, Zhu F, Fan X, Wu X, Zhao H, and Jiang L (2014a) Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor. Oncol Res 21:137-144.
56. Li Y, Zhang S, Geng JX, and Hu XY (2013) Curcumin inhibits human non-small cell lung cancer A549 cell proliferation through regulation of Bcl-2/Bax and cytochrome C. Asian Pac J Cancer Prev 14:4599-4602.
57. Li ZC, Zhang LM, Wang HB, Ma JX, and Sun JZ (2014b) Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1. Tumour Biol 35: 111-116.
58. Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, and Zhou BS (2009) Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 125:2936-2944.
59. Limburg PJ, Mandrekar SJ, Aubry MC, Ziegler KL, Zhang J, Yi JE, Henry M, Tazelaar HD, Lam S, and McWilliams A, et al; Cancer Prevention Network (2013) Randomized phase II trial of sulindac for lung cancer chemoprevention. Lung Cancer 79:254-261.
60. Lin HP, Kuo LK, and Chuu CP (2012) Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. Phytother Res 26:122-126.
61. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, and Chung JG (2009) Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett 285:127-133.
62. Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, and Fry W, et al (2001) Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 93:605-618.
63. Liu Z, Sun Y, Ren L, Huang Y, Cai Y, Weng Q, Shen X, Li X, Liang G, and Wang Y (2013) Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells. BMC Cancer 13:494.
64. Liu YL, Yang HP, Gong L, Tang CL, and Wang HJ (2011) Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines. Mol Med Rep 4:675-679.
65. Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, and Bray F (2014) International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer 84: 13-22.
66. Malaney P, Nicosia SV, and Davé V (2014) One mouse, one patient paradigm: New avatars of personalized cancer therapy. Cancer Lett 344:1-12.
67. Malhotra A, Nair P, and Dhawan DK (2011) Curcumin and resveratrol synergistically stimulate p21 and regulate cox-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 20:411-416.
68. Malhotra A, Nair P, and Dhawan DK (2012a) Curcumin and resveratrol in combination modulates benzo(a)pyrene-induced genotoxicity during lung carcinogenesis. Hum Exp Toxicol 31:1199-1206.
69. Malhotra A, Nair P, and Dhawan DK (2012b) Premature mitochondrial senescence and related ultrastructural changes during lung carcinogenesis modulation by curcumin and resveratrol. Ultrastruct Pathol 36:179-184.
70. Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, and Cameron RB, et al (2011) Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila) 4:984-993.
71. McLarty JW, Holiday DB, Girard WM, Yanagihara RH, Kummet TD, and Greenberg SD (1995) Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 62(6, Suppl)1431S-1438S.
72. Moghaddam SJ, Barta P, Mirabolfathinejad SG, Ammar-Aouchiche Z, Garza NT, Vo TT, Newman RA, Aggarwal BB, Evans CM, and Tuvim MJ, et al. (2009) Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 30:1949-1956.
73. Mogi A and Kuwano H (2011) TP53 mutations in nonsmall cell lung cancer. JBiomed Biotechnol 2011:583929.
74. Munoz J, Swanton C, and Kurzrock R (2013) Molecular profiling and the reclassification of cancer: divide and conquer. Am Soc Clin Oncol Educ Book 33:127-134.
75. Nakahara R, Yokose T, Nagai K, Nishiwaki Y, and Ochiai A (2001) Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia. Thorax 56:302-305.
76. Nemmar A, Subramaniyan D, and Ali BH (2012) Protective effect of curcumin on pulmonary and cardiovascular effects induced by repeated exposure to diesel exhaust particles in mice. PLoS ONE 7:e39554.
77. Omenn GS (2007) Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future. Eur J Cancer Prev 16:184-191.
78. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, and Williams JH, et al (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155.
79. Oxnard GR, Nguyen KS, and Costa DB (2014) Germline mutations in driver oncogenes and inherited lung cancer risk independent of smoking history. J Natl Cancer Inst 106:djt361.
80. Pan Y, Zhao W, Wang J, Liu Q, Yang G, and Li J (2009) [Establishment of a multidrug resistance cell line A549/cDDP of human lung adenocarcinoma and expression analysis of multidrug resistance-associated genes]. Zhongguo Fei Ai ZaZhi 12: 187-192.
81. Parkin DM, Bray F, Ferlay J, and Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
82. Pongrakhananon V, Nimmannit U, Luanpitpong S, Rojanasakul Y, and Chanvorachote P (2010) Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation. Apoptosis 15:574-585.
83. Prasad S, Tyagi AK, and Aggarwal BB (2014) Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 46:2-18.
84. Puliyappadamba VT, Cheriyan VT, Thulasidasan AK, Bava SV, Vinod BS, Prabhu PR, Varghese R, Bevin A, Venugopal S, and Anto RJ (2010) Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. Mol Cancer 9:220.
85. Rennolds J, Malireddy S, Hassan F, Tridandapani S, Parinandi N, Boyaka PN, and Cormet-Boyaka E (2012) Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium. Biochem Biophys Res Commun 417: 256-261.
86. Rocks N, Bekaert S, Coia I, Paulissen G, Gueders M, Evrard B, Van Heugen JC, Chiap P, Foidart JM, and Noel A, et al. (2012) Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. Br J Cancer 107:1083-1092.
87. Saha A, Kuzuhara T, Echigo N, Fujii A, Suganuma M, and Fujiki H (2010) Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of "growth arrest and DNA damage inducible genes 45 and 153". Biol Pharm Bull 33: 1291-1299.
88. Sahoo K, Dozmorov MG, Anant S, and Awasthi V (2012) The curcuminoid CLEFMA selectively induces cell death in H441 lung adenocarcinoma cells via oxidative stress. Invest New Drugs 30:558-567.
89. Saito M, Kato H, Tsuchida T, and Konaka C (1994) Chemoprevention effects on bronchial squamous metaplasia by folate and vitamin B12 in heavy smokers. Chest 106:496-499.
90. Sakurai R, Villarreal P, Husain S, Liu J, Sakurai T, Tou E, Torday JS, and Rehan VK (2013) Curcumin protects the developing lung against long-term hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 305:L301-L311.
91. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, and Bergo MO (2014) Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6: 221ra215.
92. Sehgal A, Kumar M, Jain M, and Dhawan DK (2011) Combined effects of curcumin and piperine in ameliorating benzo(a)pyrene induced DNA damage. Food Chem Toxicol 49:3002-3006.
93. Sehgal A, Kumar M, Jain M, and Dhawan DK (2012) Synergistic effects of piperine and curcumin in modulating benzo(a)pyrene induced redox imbalance in mice lungs. Toxicol Mech Methods 22:74-80.
94. Sen S, Sharma H, and Singh N (2005) Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 331:1245-1252.
95. Shi HS, Gao X, Li D, Zhang QW, Wang YS, Zheng Y, Cai LL, Zhong RM, Rui A, and Li ZY, et al (2012) A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int J Nanomedicine 7: 2601-2611.
96. Shishodia S, Potdar P, Gairola CG, and Aggarwal BB (2003) Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24:1269-1279.
97. Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R, and Salgia R (2014) Molecular pathways and therapeutic targets in lung cancer. Oncotarget 5: 1392-1433.
98. Sohal SS, Ward C, Danial W, Wood-Baker R, and Walters EH (2013) Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease. Expert Rev Respir Med 7:275-288.
99. Strohecker AM and White E (2014) Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Autophagy 10:384-385.
100. Su CC, Yang JS, Lu CC, Chiang JH, Wu CL, Lin JJ, Lai KC, Hsia TC, Lu HF, and Fan MJ, et al (2010) Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model. Phytother Res 24:189-192.
101. Subramani PA and Narala VR (2013) Challenges of curcumin bioavailability: novel aerosol remedies. Nat Prod Commun 8:121-124.
102. Sun S, Schiller JH, and Gazdar AF (2007) Lung cancer in never smokers - a different disease. Nat Rev Cancer 7:778-790.
103. Suresh MV, Wagner MC, Rosania GR, Stringer KA, Min KA, Risler L, Shen DD, Georges GE, Reddy AT, and Parkkinen J, et al (2012) Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury. Am J Respir Cell Mol Biol 47:280-287.
104. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Odajima N, Moriyama C, Nasuhara Y, and Nishimura M (2009) Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 296: L614-L623.
105. Szabo E (2006) Selecting targets for cancer prevention: where do we go from here? Nat Rev Cancer 6:867-874.
106. Szabo E, Mao JT, Lam S, Reid ME, and Keith RL (2013) Chemoprevention of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e40S-60S.
107. The ATBC Cancer Prevention Study Group (1994) The alpha-tocipherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4:1-10.
108. Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, and Hoffman S (2004) Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol 31:28-35.
109. Travis WD, Brambilla E, and Riely GJ (2013) New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. J Clin Oncol 31:992-1001.
110. Tung YT, Chen HL, Lai CW, Shen CJ, Lai YW, and Chen CM (2011) Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice. Mol Nutr Food Res 55:1036-1043.
111. Vanisree AJ and Sudha N (2006) Curcumin combats against cigarette smoke and ethanol-induced lipid alterations in rat lung and liver. Mol Cell Biochem 288: 115-123.
112. van Poppel G, Kok FJ, and Hermus RJ (1992) Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. Br J Cancer 66: 1164-1168.
113. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, and van Tinteren H (2000) EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 92:977-986.
114. Veronesi G, Szabo E, Decensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D, Ferretti S, Pelosi G, Lazzeroni M, and Serrano D, et al. (2011) Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res (Phila) 4:34-42.
115. Wang BL, Shen YM, Zhang QW, Li YL, Luo M, Liu Z, Li Y, Qian ZY, Gao X, and Shi HS (2013a) Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomedicine 8:3521-3531.
116. Wang Y, Xiao J, Zhou H, Yang S, Wu X, Jiang C, Zhao Y, Liang D, Li X, and Liang G (2011) A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis (2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway. J Med Chem 54: 3768-3778.
117. Wang P, Zhang L, Peng H, Li Y, Xiong J, and Xu Z (2013b) The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C Mater Biol Appl 33:4802-4808.
118. Wu SH, Hang LW, Yang JS, Chen HY, Lin HY, Chiang JH, Lu CC, Yang JL, Lai TY, and Ko YC, et al (2010) Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res 30:2125-2133.
119. Xiao K, Jiang J, Guan C, Dong C, Wang G, Bai L, Sun J, Hu C, and Bai C (2013) Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J Pharmacol Sci 123:102-109.
120. Xiao X, Yang M, Sun D, and Sun S (2012) Curcumin protects against sepsis-induced acute lung injury in rats. J Surg Res 176:e31-e39.
121. Xu M, Deng B, Chow YL, Zhao ZZ, and Hu B (2007) Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. J Ethnopharmacol 112:292-299.
122. Xu F, Diao R, Liu J, Kang Y, Wang X and Shi L (2014) Curcumin attenuates staphylococcus aureus-induced acute lung injury. Clin Respir J DOI: 10.1111/crj.12113 [published ahead of print].
123. Yamauchi Y, Izumi Y, Yamamoto J, and Nomori H (2014) Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. Phytother Res 28:728-735.
124. Yan L (2013) Dietary supplementation with curcumin enhances metastatic growth of Lewis lung carcinoma in mice. Int J Cancer 132:269-275.
125. Yang CL, Liu YY, Ma YG, Xue YX, Liu DG, Ren Y, Liu XB, Li Y, and Li Z (2012a) Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS ONE 7:e37960.
126. Yang CL, Ma YG, Xue YX, Liu YY, Xie H, and Qiu GR (2012b) Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway. DNA Cell Biol 31:139-150.
127. Ye MX, Zhao YL, Li Y, Miao Q, Li ZK, Ren XL, Song LQ, Yin H, and Zhang J (2012) Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Phytomedicine 19:779-787.
128. Yen FL, Tsai MH, Yang CM, Liang CJ, Lin CC, Chiang YC, Lee HC, Ko HH, and Lee CW (2013) Curcumin nanoparticles ameliorate ICAM-1 expression in TNF-α-treated lung epithelial cells through p47 (phox) and MAPKs/AP-1 pathways. PLoS ONE 8:e63845.
129. Yin H, Guo R, Xu Y, Zheng Y, Hou Z, Dai X, Zhang Z, Zheng D, and Xu H (2012) Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer. Acta Biochim Biophys Sin (Shanghai) 44:147-153.
130. Yin H, Zhang H, and Liu B (2013a) Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim Biophys Sin (Shanghai) 45: 634-640.
131. Yin HT, Zhang DG, Wu XL, Huang XE, and Chen G (2013b) In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev 14:409-412.
132. * signaling pathway. Oncol Rep 24:1217-1223.
133. Zhang Z, Niu X, Lu C, Jiang M, Xiao GG, and Lu A (2012) The effect of curcumin on human bronchial epithelial cells exposed to fine particulate matter: a predictive analysis. Molecules 17:12406-12426.
134. Zhang XC, Zhang J, Li M, Huang XS, Yang XN, Zhong WZ, Xie L, Zhang L, Zhou M, and Gavine P, et al (2013) Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies. J Transl Med 11: 168.
135. Zhang J, Zhang T, Ti X, Shi J, Wu C, Ren X, and Yin H (2010b) Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway. Biochem Biophys Res Commun 399:1-6.
136. Zhou B, Huang J, Zuo Y, Li B, Guo Q, Cui B, Shao W, Du J, and Bu X (2013a) 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage. Eur J Pharmacol 707:130-139.
137. Zhou GZ, Zhang SN, Zhang L, Sun GC, and Chen XB (2014) A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells. Pharm Biol 52:111-116.
138. Zhou B, Zuo Y, Li B, Wang H, Liu H, Wang X, Qiu X, Hu Y, Wen S, and Du J, et al. (2013b) Deubiquitinase inhibition of 19S regulatory particles by 4-arylidene curcumin analog AC17 causes NF-kB inhibition and p53 reactivation in human lung cancer cells. Mol Cancer Ther 12:1381-1392.